Tag: pharmaceuticals
-
Leukemia Drug Shows Potential as Heart Attack Therapy
A new drug being tested as a leukemia treatment was shown in lab mice to reduce inflammatory white blood cells that lead to a build-up of arterial plaques and heart disease.
-
Robo-Bacteria Engineered for Cancer Drug Delivery
A biomedical engineering team designed a technology for precise deployment of drugs to tumors with bacteria modified to deliver their cargoes.
-
Gene Editing Negates Sickle Cell to Create Healthy Blood
Medical researchers developed a technique with genome editing to negate the effects of a mutation that causes inherited blood disorders like sickle cell disease.
-
Molecular Express, Baylor Medicine Partner on Vaccines
Vaccine developer Molecular Express and Baylor College of Medicine in Houston are developing boosters for vaccines from pieces of viruses that increase immune response to disease, including cancer.
-
Biopharm Company Raising $40 Million in IPO
Omeros Corporation, a biopharmaceutical company developing drugs that prevent inflammation in surgeries, is raising $40 million in its initial public stock offering.
-
Patent Advances for Gut Damage Treatment Delivery
A developer of therapies for damage to an intestinal barrier received a notice that the U.S. intends to issue a patent protecting the technology to deliver the treatments.
-
Stem Cells Banked for Bipolar Disorder Research
Stem cells from people with bipolar disorder are being collected by an academic-industry partnership for scientists worldwide who study the disorder.
-
Cocaine Vaccine Trial Recruitment Underway
An early-stage clinical trial testing a vaccine designed to prevent cocaine from reaching the brain started recruiting participants in New York.
-
FDA Funding Brain Tumor Treatment Trial
The biotechnology company DNAtrix is receiving a grant from U.S. Food and Drug Administration to support a clinical trial of its virus-delivered immunotherapy to treat an aggressive form of brain cancer.
-
Amgen, Advaxis Partner on Personal Cancer Immunotherapy
Biological drug maker Amgen is licensing precision immunotherapy technology from Advaxis Inc. to develop treatments for cancer.